drugset / Trial / NCT01310400

Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children

NCT01310400

Phase 3 Completed 1356 enrolled Crucell Holland BV
RandomizedParallel-groupSingle-blindTreatment

Summary

A study to assess whether the Northern Hemisphere 2009/2010 season influenza vaccine Inflexal V is as immunogenic as a locally sourced competitor vaccine in young children.

Timeline

Start
2009-10
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Agrippal Vaccine 0.25 ml Intramuscular
Subject Inflexal V Vaccine 0.25 ml Intramuscular
Subject Inflexal V Vaccine 0.5 ml Intramuscular

Indications